Genetic diversity of rotavirus group A: Correlation between G3 type and severity of the infection. Valencia, Venezuela;Diversidad genotípica de rotavirus grupo A: Correlación entre el tipo G3 y severidad de la infección. Valencia, Venezuela

Investigacion Clinica (Venezuela)

Volumn 54, Issue 1, 2013, Pages 34-46

  González, Rosabel ^a   Rivero, Lisbeth ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; GENETIC VARIABILITY; HUMAN; MIXED INFECTION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; STOMACH EMPTYING; VIRUS DETECTION; VOMITING;

ACUTE DISEASE; CHILD, PRESCHOOL; DIARRHEA; DIARRHEA, INFANTILE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MORBIDITY; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEROTYPING; SEVERITY OF ILLNESS INDEX; VENEZUELA;

EID: 84876496659     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by RV disease in children. Emerg Infect Dis 2003; 9:565-572.
2. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200(Suppl 1):S9-S15.
3. Cunliffe NA, Booth JA, Elliot C, Lowe SJ, Sopwith L, Kitchin N, Nakagomi O, Nakagomi T, Hart A, Regan M. Healthcare- associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom. Emerg Infect Dis 2010; 16:55-62.
4. Justino MC, Araújo EC, van Doorn Leen Jan, Oliveira CS, Gabbay JB, Mascarenhas J, Miranda YS, Guerra S de Fátima, da Silva VB, Linhares A. Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children. Mem Inst Oswaldo Cruz 2012; 107: 846-853.
5. Salinas B, González G, González R, Escalona M, Materán M, Pérez Schael I. Epidemiologic and clinical characteristics of RV disease during five years of surveillance in Venezuela. Pediatr Infec Dis J 2004; 23 (Suppl): S161-167.
6. Pérez-Schael I, Salinas B, González R, Salas H, Ludert JE, Escalona M, Alcalá A, Rosas MA, Materán M. Rotavirus mortality confirmed by etiologic identification in Venezuelan children with diarrhea. Pediatr Infec Dis 2007; 26: 393-397.
7. Estes MK, Kapiquian AZ. Rotaviruses. En: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editores. Fiels Virology, 5ta ed. Philadelphia: Kluwer Health/Lippincott, Williams and Wilkins. 2007. pp 1917-1974.
8. Santos N, Hoshino Y. Global distribution of RV serotypes/genotypes and its implication for the development and implementation of an effective RV vaccine. Rev Med Virol 2005; 15: 29-56.
9. Nokes DJ, Peenze I, Netshifhefhe L, Abwao J, De Beer MC, Seheri LM, Williams TN, Page N, Steele D. Rotavirus ge- netic diversity, disease association and temporal change in hospitalized rural Kenyan children. J Infect Dis 2010; 1: S180-S186.
10. Bahl R, Ray P, Subodh S, Shambharkar P, Saxena M, Parashar U, Gentsch J, Glass R, Bhan MK. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 2005; 192: S114-S119.
11. Castello AA, Arguelles MH, Rota RP, Olthoff A, Jiang B, Glass RI, Gentsch JR, Glikmann G. Molecular epidemiology of group A RV diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12. J Clin Microbiol 2006; 44: 2046-2050.
12. Armah G, Hoshino Y, Santos N, Binka F, Damanka S, Adjei R, Honma S, Tatsumi M, Manful T, Anto F. The global spread of rotavirus G10 strains. Detection in Ghanaian children hospitalized with diarrhea. J Infect Dis 2010; 1: S231-S238.
13. MCDonald SM, Matthijnssens J, McAllen JK, Hine E, Overton L, Wang S, Lemey P, Zeller M, Van Ranst M, Spiro DJ, Patton JT. Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PloS Pathog. 2009; 5(10): e1000634 [acceso Ene 2011].
14. Bern C, Unicomb L, Gentsch J, Banul N, Yunus M, Sack RB, Glass RI. RV diarrhea in Bangladeshi children: correlation of disease severity with serotypes. J Clinl Microbiol 1992; 30: 3234-3238.
15. Cascio A, Vizzi E, Alaimo C, Arista S. RV gastroenteritis in Italian children: can severity of symptoms be related to the infecting virus? Clin Infect Dis 2001; 32: 1126-1132.
16. Mota-Hernández F, Calva JJ, Gutierrez- Camacho C, Contreras-Villa S, Arias CF, Padilla-Noriega L, Guiscafré-Gallardo, Guerrero ML, López S, Muñoz O, Contreras JF, Cedillo R, Herrera I, Puerto IF. RV diarrhea severity is related to the VP4 type in Mexican Children. J Clin Microbiol 2003; 41: 3158-3162.
17. Linhares AC, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis 2006; 43:312-314.
18. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M, Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22.
19. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33.
20. Gentsch JR, Parashar UD, Glass RI. Impact of rotavirus vaccination: the importance of monitoring strains. Future Microbiol 2009; 4: 1231-1234.
21. World Health Organization. Manual of rotavirus detection and characterization methods. Geneva, Switzerland: World Health Organization; 2009.
22. World Health Organization (WHO). A Manual for the treatment of diarrhea: for use by physicians and other senior health workers. Geneva: World Health Organization; 1990.
23. World Health Organization (WHO). WHO child growth standards 2006. Available on: www.who.int/chilgrowth/en. Acceso Dic. 2009.
24. Méndez-Castellano H, De Méndez MC. Estratificación social y biología humana: método Graffar modificado. Arch Venez Puerc Pediatr 1986; 49:93-104.
25. González R, Salas-Maronsky H, Balebona E, Martínez JR, Serrano N, Pérez-Schael I. Estudio epidemiológico de las diarreas por rotavirus en niños menores de 5 años atendidos en centros asistenciales del estado Miranda-Venezuela. Invest Clin 2008; 49: 499-510.
26. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang Zhao-Yin. Polymerase chain reaction amplification and typing of RV nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-282.
27. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK. Identification of group A RV gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30: 1365-1373.
28. Santos N, Volotao EM, Soares CC, Albuquerque MC, da Silva FM, Chizhikov V, Hoshino Y. VP7 gene poymorphism of serotype G9 rotavirus strains and its impact on G genotype determination by PCR. Virus Res 2003; 93: 127-138.
29. Ruuska T, Vesikari T. Rotavirus disease in Finnnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22: 259-267.
30. Glass RI, Bhan MK, Ray P, Bahl R, Parashar UD, Greenberg H, Rao CD, Bhandari N, Maldonado Y, Ward RL, Bernstein DI, Gentsch JR. Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 2005; 192: S30-S35.
31. Bhandari N, Sharma P, Glass RI. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomized controlled trial. Vaccine 2006; 24: 5817-5823.
32. Maldonado AJ, Bastardo JW. Epidemiología molecular de rotavirus humanos en Cumaná, Venezuela. Act Cient Venez 1992; 43:368-372.
33. Pérez-Schael I, González R, Fernández R, Alfonso E, Inaty D, Boher Y, Sarmiento L. Epidemiological features of RV infection in Caracas, Venezuela: Implications for RV immunization programs. J Med Virol 1999; 59:520-526
34. Urrestarazu M, Liprandi F, Pérez de Suarez E, González R, Pérez-Schael I. Características etiológicas, clínicas y sociodemográficas de la diarrea aguda en Venezuela. Pan Am J Public Health 1999; 6: 149-156.
35. Rojas Y, Bastardo J, Sulbarán M. Prevalencia de rotavirus y su relación con factores climáticos en Cumaná, Venezuela. Kasmera 2003; 31: 20-28.
36. Vizzi E, Piñeros O, González GG, Zambrano JL, Ludert JE, Liprandi F. Genotyping of human rotaviruses circulating among children with diarrhea in Valencia, Venezuela. J Med Virol 2011; 83: 2225-2232.
37. Munford V, Gilio AE, Correa de Souza E, Morais Cardoso D, das Dores de Paula Cardoso D, Tavares Borges AM, Sucasas de Costa PS, Melo Melgaco IA, Rosa H, Antonacci Carvalho PR, Zubaran Goldani M, Duarte Moreia E, Santana C, El Khoury A, Ikedo F, Rácz ML. Rotavirus gastroenteritis in children in 4 regions in Brazil: a hospital-based surveillance study. J Infect Dis 2009; 1: S106-S113.
38. Zuccotti G, Meneghin F, Dilillo D, Romano L, Bottone R, Mantegazza C, Giacchino R, Besana R, Ricciardi G, Sterpa A, Altamira N, Andreotti M, Montrasio G, Macchi L, Pavan A, Paladín S, Zanetti A, Radaelli G. Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalizaed with acute gastroenteritis in northern Italy. BMC Infect Dis 2010; 10: 218-215.
39. Nozawa CM, Kerntopf GF, da Silva Czernisz E, Albuquerque D, Romaní P, Freitas JF, Santos N, Benati FJ, Pietruchinski E, Cavalho Linhares RE. Detection and characterization of human rotavirus in hospitalizad patients in the cities of Ponta Grossa, Londrina and Assai- Pr, Brazil. Braz J Infect Dis 2010; 14(6):553-557.
40. Velázquez FR, Matson DO, Calva JJ, Guerrero ML, Morrow AL, Carter-Camp- bell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios M. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022-1028.
41. Franco M, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006; 24: 2718-2731.
42. Velázquez FR. Protective effects of natural rotavirus infection. Pediatr Infect Dis J 2009; 28: 554-556.
43. White L, García D, Boher Y, Blanco M, Pérez M, Romer H, Flores J, Pérez-Schael I. Temporal distribution of human rotavirus serotypes 1,2,3 and 4 in venezuelan children with gastroenteritis during 1979- 1989. J Med Virol 1991; 34: 79-84.
44. Salinas B, Pérez-Schael I, Linhares AC, Ruiz-Palacios G, Guerrero L, Yarzábal JP, Cervantes Y, Costa S, Damasco S, Hardt K, De Vos B. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414. Pediatr Infect Dis 2005; 24: 807-816.
45. Lihnares AC, Velázquez RF, Pérez-Schael I, Llrens-Sáez X, Abate E, Espinosa F, López P, Macías-Parra M, Ortega-Barrios E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruíz-Palacios GM, De Vos B, O'Ryan M, Gillar P, Bouckenooghe A, and the Human Rotavirus Vaccine Study Group. Efficacy and safety an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of live in Latin American infants: a randomized, double-blind, placebo-controlled phase III study. Lancet 2008; 371: 1181-1189.
46. Bok K, Palacios G, Sijvarger K, Matson D, Gomez J. Emergence of G9P[6]human rotavirus in Argentina: phylogenetic relationships among G9 strains. J Clin Microbiol 2001; 39:4020-4025.
47. Coluchi N, Munford V, Manzur J, Vazquez C, Escobar M, Weber E, Mármol P, Racz ML. Detection subgroup specificity and genotype diversity of rotavirus strains in children with acute diarrhea in Paraguay. J Clin Microbiol 2002; 40: 1709-1714.
48. Solberg O, Hasing ME, Trueba G, Eisenberg J. Characterization of novel VP7, VP4, and VP6 genotypes of a previously untypeable group A rotavirus. Virology 2009; 385: 58-67.
49. Martella V, Terio V, Arista S, Elia G, Corrente M, Madio A, Pratelli A, Tempesta M, Cirani A, Buonavoglia C. Nucleotide variation in the VP7 gene affects PCR genotyping of G9 rotaviruses identified in Italy. J Med Virol 2004; 72: 143-148.
50. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Microbiol 2004; 31: 259-265.
51. Polanco G, Gozález M, Rodríguez E, Manzano L, Cámara J, Puerto M. Clinical manifestation of the rotavirus infection and his relation with the electropherotypes and serotypes detected during 1998 and 1999 in Merida, Yucatán, Mexico. J Clin Virol 2003; 27: 242-246.
52. Widdowson MA, van Doornum GJJ, van der Poel WHM, de Boer AS, Mahdi U, Koopmans M. Emerging group-A rotavirus and nosocomial outbreak of diarrhea. Lancet 2000; 356: 1161-1162.
53. Rosa e Silva ML, Pires de Carvalho I, Gouvea V.1998-1999 rotavirus seasons in Juiz de Fora, Minas Gerais, Brazil: detection of unusual G3P[4] epidemic strain. J Clin Microbiol 2002; 40: 2837-2842.
54. Pérez-Schael I. Vacuna de rotavirus: un recorrido exitoso en Venezuela. Clemente Heimerdinger A, Briceño-Iragorry L, editores. Colección Razzetti. Volumen VIII. Caracas: Editorial Ateproca; 2009; 63-88.